Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of ALK House Dust Mite Allergy Immunotherapy Tablet in Subjects With House Dust Mite Induced Asthma. The MITRA Trial

NCT01433523 is registered in ClinicalTrials.gov with ALK-Abelló A/S as lead sponsor.

NCT NCT01433523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01433523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of ALK House Dust Mite Allergy Immunotherapy Tablet in Subjects With House Dust Mite Induced Asthma. The MITRA Trial
Lead sponsor
ALK-Abelló A/S
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2011
Completion date
February 28, 2014
Enrollment
834 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma